Search Results for: DNA VACCINE TECHNOLOGY A Vaccine

Articles

- 9/6/2011

Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...

- 10/17/2011

Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...

- 4/3/2012

Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...

- 4/17/2012

Ei Increases Capabilities Through New Partnership Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun...

- 5/16/2012

Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...

- 7/18/2012

Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc....

- 1/23/2012

Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas...

- 3/6/2013

Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...

- DELIVERY DEVICES – The New Industry Paradigm for Prefilled Success

Alan Shortall indicates that following a period of relative industry stability defined by peripheral innovation, a converging series of external and internal forces are set to reshape the prefilled syringe industry so that it will better serve the emerging needs of pharmaceutical companies, patients, and other stakeholders across the continuum of care.

- INTRADERMAL DELIVERY – Advances in Intradermal Drug Delivery

Zach Marks, MS, RPh, believes efficiency of vaccine use will be critical as the world population continues to grow and vaccine prices continue to rise, and ID administration can help reduce dose cost while potentially improving immunogenicity in traditional and hard-to-treat populations.